MAGSTIM LAUNCHES HORIZON PERFORMANCE CART FOLLOWING CE & FDA APPROVAL
Magstim, the pioneer of a revolutionary non-invasive treatment for depression, has announced that its latest TMS therapy product, the Horizon Performance, has achieved CE mark regulatory approval and 510(k) clearance from the FDA.
Magstim's Transcranial Magnetic Stimulation (TMS) is an innovative and proven therapy which uses a series of repetitive, brief and focused magnetic pulses to stimulate brain cells.
TMS is being increasingly adopted by psychiatrists in cases where antidepressant medication is ineffective.
Using our versatile Synergy Cart we are proud to have collaborated with Magstim and Vertiv on the design, development and implementation of this project.